Indication
Homozygous Familial Hypercholesterolemia
The Homozygous Familial Hypercholesterolemia pipeline: 2 tracked drugs.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Homozygous Familial Hypercholesterolemia, so this list is not complete.
1 Phase 31 preclinical / unstaged
Compare the share prices of listed companies in Homozygous Familial Hypercholesterolemia →
Market size not yet sourced. How markets are sized ↗